READ : THIS DEAL IS NOT JUST ABOUT TAX BENEFITS . THIS DEAL IS ABOUT GREAT FRANCHISES . BRENT CAN TALK ABOUT THE FRANCHISES ALLERGAN HAS IN A SECOND . I ' M EXCITED ABOUT IT . IT TAKES OUR TWO BUSINESSES ARE ESTABLISHED BUSINESS AND OUR INNOVATIVE PHARMACEUTICAL IT GIVES IT GREATER GROWTH , IT GIVES IT BRIGHTER PORTFOLIO . IT ' S A REALLY STRATEGIC DEAL FROM THAT POINT OF VIEW . IT ENABLES US TO INCORPORATE BRENT ' S OPEN SCIENCE , OPEN DEVELOPMENT PHILOSOPHY WE GET OVERLAP SYNERGIES WE GET FROM OVERLAPS . THERE ARE BENEFITS FROM TAX . IF THE BENEFITS FROM TAX WEREN ' T THERE , I WOULD STILL TRY TO DO THE DEAL , BUT I SUSPECT THE PRICE WOULD BE DIFFERENT .
